Testing for tumor DNA in blood after early-stage breast cancer surgery
Part of Cancer, Skin clinical trials.
This study looks for tiny bits of tumor DNA in your blood after surgery to see if it can help guide future treatment. It's for people who had surgery first (not chemotherapy before surgery) and have not seen the cancer spread.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You had surgery to remove the tumor, and there is enough leftover tumor tissue to test.
- You did not receive chemotherapy or hormone therapy before surgery.
- You have no signs that the cancer has spread to other parts of the body.
- Cancer cells were not just found as single cells or tiny groups in your lymph nodes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new blood test to see if it can find tiny bits of tumor DNA after chemotherapy. If you have a larger or higher-risk breast cancer and are getting chemotherapy before surgery, you may join. The test could help doctors know if your cancer is gone or if more treatment is needed.
This trial uses a special blood test to track cancer signals (called ctDNA) during and after treatment for early breast cancer. It aims to see whether monitoring these signals can help guide follow-up and treatment decisions.
This study looks for tiny traces of cancer left in the body after treatment and surgery. It may help doctors understand if the cancer could come back, so it can be caught and treated earlier.
This study looks at a blood test for “circulating tumor DNA” (tiny pieces of cancer-related DNA in the blood). It may help doctors learn more about digestive, gynecologic, or breast cancers and how patients respond when treatment like chemotherapy or immunotherapy is needed.
This trial checks a blood test called circulating tumor DNA to help choose the best time and approach for chemotherapy after colon cancer surgery. It aims to reduce recurrence by identifying people who may benefit from treatment based on changes seen in the blood.
This study checks whether a special blood test (ctDNA) taken before and after surgery can predict whether non-small cell lung cancer will come back. If it works, it may help doctors spot recurrence earlier and guide follow-up care after tumor removal.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.